🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Kalifòni › Los Angeles

Etid klinik pou Sendwòm myelodisplastik nan Los Angeles, CA

10 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Cedars-Sinai Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Ap rekriteFaz 1/2
  • UCLA, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Ap rekriteFaz 1/2
  • University of California, Los Angeles, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT05308264

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • UCLA Department of Medicine, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • Oncology Institute for Hope and Innovation, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • Keck School of Medicine of USC, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Ap rekriteFaz 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06063486

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Ap rekriteFaz 1
  • UCLA, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT05143996

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Ap rekriteFaz 1
  • University of California Los Angeles, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT06501196

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.